SNSE
Sensei Biotherapeutics Inc
NASDAQ: SNSE · HEALTHCARE · BIOTECHNOLOGY
$26.62
-5.94% today
Updated 2026-04-30
Market cap
$39.04M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-16.72
Dividend yield
—
52W range
$5 – $37
Volume
0.1M
Sensei Biotherapeutics Inc (SNSE) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-10.31M | $-8.57M | $-17.70M | $-30.26M | $-39.03M | $-32.02M | $-24.67M | $-20.45M |
| Capital expenditures | $31000.00 | $53000.00 | $1.21M | $2.03M | $321000.00 | $180000.00 | $146000.00 | $16000.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.19M | $1.18M | $1.49M | $5.66M | $5.81M | $4.45M | $3.13M | $1.27M |
| Free cash flow | $-10.34M | $-8.62M | $-18.91M | $-32.28M | $-39.35M | $-32.20M | $-24.82M | $-20.47M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |